Suiseng Coli / C inj. susp. i.m. vial

Land: Belgia

Språk: engelsk

Kilde: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktiv ingrediens:

Escherichia coli F6 fimbrial adhesin ; Eschericia coli LT-enterotoxoïd ; Escherichia coli F4ac fimbrial adhesin ; Escherichia coli F4ab fimbrial adhesin ; Clostridium novyi toxoid ; Escherichia coli F5 fimbrial adhesin ; Clostridium perfringens type C toxoid

Tilgjengelig fra:

Laboratorios Hipra S.A.

ATC-kode:

QI09AB08

INN (International Name):

Clostridium Perfringens; Clostridium Novyi Toxoid; Escherichia Coli Enterotoxin LT; Escherichia Coli Adhesins

Legemiddelform:

Suspension for injection

Sammensetning:

Clostridium Perfringens; Clostridium Novyi Toxoid; Escherichia Coli Enterotoxin LT; Escherichia Coli Adhesins

Administreringsrute:

Intramuscular use

Terapeutisk gruppe:

pig

Terapeutisk område:

Escherichia + Clostridium

Produkt oppsummering:

CTI code: 561902-01 - Pack size: 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 561893-03 - Pack size: 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 561893-01 - Pack size: 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 561893-02 - Pack size: 25 doses (50 (50) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 561902-04 - Pack size: 125 doses (250 (250) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 561902-03 - Pack size: 50 doses (100 (100) - Commercialisation status: YES - CNK code: 4473021 - Delivery mode: Medical prescription; CTI code: 561902-02 - Pack size: 25 doses (50 (50) - Commercialisation status: NO - Delivery mode: Medical prescription

Autorisasjon status:

Commercialised: No

Autorisasjon dato:

2020-05-19